Related Experiment Videos
[Inhibitory effect of recombinant human interferon gamma on human osteoblastic osteosarcoma cells (SaOS2)]
Abstract:
Recent studies have suggested that interleukin-1 or tumor necrosis factor-stimulated bone resorption is mediated by osteoclast-activating factor elaborated by osteoblastic cells. Since recombinant interferon gamma inhibits stimulation of bone resorption by these cytokines, we examined here the effects of recombinant human interferon gamma (rhIFN-G) on DNA synthesis and alkaline phosphatase (ALP) activity of a human osteoblastic osteosarcoma cell line, SaOS2, under preconfluent culture conditions. Addition of rhIFN-G to the cells markedly inhibited their DNA synthesis and ALP activity in a dose-dependent fashion. However, the inhibition was not dependent on the culture time. The highest inhibitory effect was observed in 10% serum-containing culture medium. The inhibitory effect on DNA synthesis was not eliminated by addition of indomethacin, a cyclooxygenase inhibitor. Furthermore, combination of rhIFN-G and recombinant human tumor necrosis factor alpha inhibited their DNA synthesis and the ALP activity in synergistic fashion. Therefore, these data suggest that rhIFN-G is a potent inhibitor for human osteoblastic cells.
Insights
Recombinant human interferon gamma (rhIFN-G) potently inhibits human osteoblastic cells, reducing DNA synthesis and alkaline phosphatase activity. This suggests rhIFN-G is a key inhibitor for osteoblastic cells in bone resorption.
Area of Science:
- Cell Biology
- Biochemistry
- Immunology
Context:
- Osteoclastic bone resorption is influenced by osteoblastic cells.
- Interleukin-1 and tumor necrosis factor stimulate bone resorption.
- Recombinant interferon gamma (rhIFN-G) has shown inhibitory effects on cytokine-stimulated bone resorption.
Purpose:
- To investigate the effects of rhIFN-G on human osteoblastic cells.
- To assess rhIFN-G's impact on DNA synthesis and alkaline phosphatase (ALP) activity in SaOS2 cells.
Summary:
- rhIFN-G significantly inhibited DNA synthesis and ALP activity in SaOS2 cells in a dose-dependent manner.
- The inhibitory effect was most pronounced in 10% serum-containing medium and was not time-dependent.
- Indomethacin did not reverse the inhibition of DNA synthesis, and rhIFN-G synergistically enhanced the inhibitory effects of tumor necrosis factor alpha.
Impact:
- rhIFN-G is identified as a potent inhibitor of human osteoblastic cells.
- These findings contribute to understanding the regulation of bone resorption.
- Potential therapeutic implications for bone-related diseases involving osteoblastic activity.